Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methotrexate interference with latent tuberculosis screening tests in adults with psoriasis
RBR-2mt78bCompleted
- Sponsor
- Universidade Federal de Pernambuco
- Start
- May 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of methotrexate in psoriasis, sponsored by Universidade Federal de Pernambuco. Primary endpoints: Change in tuberculin skin test after methotrexate and Change in QuantiFERON after methotrexate. Started May 2015; status: completed.
02
Drugs
methotrexate
03
Conditions
psoriasis
Beyond the preview
Go deeper on RBR-2mt78b.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-2mt78b.